Type(s) of Cancer
Sarcoma
Sarcoma
Study Phase
Phase 3
Study Completion Date
2021-03-31
2021-03-31
NCT02306161Uploaded 08-31-2024
Access via NCI by Request
PDS UID: nci-data-553
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Files: NCT02306161-D1
Data DictionaryNCT02306161-D1-Data-Dictionary.pdf
DATANCT02306161-D1-Dataset.csv
OTHERREADME.pdf
Files: NCT02306161-D2
Data DictionaryNCT02306161-D2-Data-Dictionary.pdf
DATANCT02306161-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT02306161-D3
Data DictionaryNCT02306161-D3-Data-Dictionary.pdf
DATANCT02306161-D3-Dataset.csv
OTHERREADME.pdf
Files: NCT02306161-D4
Data DictionaryNCT02306161-D4-Data-Dictionary.pdf
DATANCT02306161-D4-Dataset.csv
OTHERREADME.pdf
Files: NCT02306161-D5
Data DictionaryNCT02306161-D5-Data-Dictionary.pdf
DATANCT02306161-D5-Dataset.csv
OTHERREADME.pdf